Outcomes of different lines of keratoconus management in a tertiary eye center in north China

INTRODUCTION

There are racial differences in the presentation of keratoconus

.Both Asians and Caucasians were studied by Pearson

.Compared with Caucasians, Asians were found to have a fourfold increase in keratoconus incidence, with younger presentation and earlier requirement for corneal grafting.Our current study presents a large-scale Asian population of keratoconic patients. The average age of the patients at the initial diagnosis was consistent with previous reports involving Asians

. The ratio of male to female was 3.7:1, which was consistent with most previous studies.

At present, rigid gas permeable (RGP) lens wear, corneal collagen crosslinking (CXL) and keratoplasty are the main treatments for keratoconus

. However, there has been no adequate clinical classification system developed for keratoconus; the historical Amsler-Krumeich classification does not incorporate current information and technological advances

. Many studies have explored and establishing a new classification system for keratoconus, but no scheme has involved therapeutic classification

. A therapeutic classification that is reasonably accurate and readily adoptable could help us to answer the challenging question regarding which treatment is most appropriate for different stages of keratoconus. Shandong Eye Institute is a tertiary eye center in north China capable of providing a variety of treatment options for keratoconic patients, such as RGP, CXL, and corneal transplantation. We retrospectively studied our population of keratoconic patients over a 20-year period to evaluate the outcomes of different treatment approaches and to provide data to inform further research.

坤二少爺自幼聰穎，三歲能背唐詩百首，四歲呤詩作賦，鄉(xiāng)人謂之神童。只憾張神童生逢亂世，讀至縣立麟山中學(xué)時，尚未完成學(xué)業(yè)學(xué)校停辦，便輟學(xué)回鄉(xiāng)。適逢老父過世，長兄張鐵頭闖蕩江湖，油坊無人打理，便子承父業(yè)，年方十六做了油坊主。

SUBJECTS AND METHODS

This study was approved by the Ethics Committee of Shandong Eye Institute and adhered to the tenets of the Declaration of Helsinki. Informed consent was obtained from all subjects in this study. None participants received a stipend. Medical records of patients with keratoconus treated with RGP lens wear, CXL, and corneal transplantation at Shandong Eye Institute between January 1997 and December 2017 were reviewed. Patients with other concurrent eye diseases or previous eye surgeries were excluded.

When the steep K was between 52 to 60 D, the BCVA in the eyes treated with RGP lens, CXL and LKP was 0.16±0.25,0.14±0.14, and 0.15±0.12 logMAR respectively (

=0.442).The TA in the eyes treated with RGP lens, CXL, LKP and PKP was 4.1±2.2, 4.1±2.5, 4.0±2.8, and 4.2±2.0 D, respectively(

=0.97).

Statistical analyses were performed using SPSS (version 22.0,IBM SPSS Inc., Chicago, IL, USA). Descriptive statistics were reported as means±standard deviation (SD). Normality of data distribution was tested using the 1-sample Kolmogorov-Smirnov test. Differences between before and after treatment were assessed with the paired-samples

-test if variables had a normal distribution and with the Wilcoxon signed-rank test if the variables did not have a normal distribution. Differences in steep K groups were assessed with the one-way analysis of variance (ANOVA) if variables had a normal distribution with equal variance and with the Mann-Whitney

test or the Kruskal-Wallis test if the variables did not have a normal distribution or had unequal variance. The endothelial cell density (ECD) between the lamellar keratoplasty (LKP) and penetrating keratoplasty (PKP) groups at different time points was assessed with the Mann-Whitney

test. Frequency analyses were performed using the Fisher's exact Chi-square test. Basic characteristic differences between the treatment groups were compared using ANOVA. Logistic regression analysis was used to detect the related factors for keratoplasty options. The receiver operating characteristic (ROC) curve analysis was performed to test the ability of analysed variables to distinguish between keratoplasty and non-keratoplasty. The area under the receiver operating characteristic curve (AUC)with 95% confidence interval (95%CI) was estimated, and the optimal cut-off values were determined. Comparison of the area under the AUCs was performed using the z-test. Twotailed

values less than 0.05 were considered statistically significant.

As the time span of this study was large, only the results from the same type of corneal topography systems for individual patients were included to avoid any errors caused by instrument difference. The corneal topography equipment included the Tomey screening system (Tomey Corp, Nagoya, Japan),the Obscan II (Bausch & Lomb, Rochester, NY, USA), and the Oculus Pentacam (Oculus Optikgerate GmbH, Wetzlar,Germany).

The patients were grouped into a mild-moderate group and an advanced group according to the CLEK (the Collaborative Longitudinal Evaluation of Keratoconus) Study

. The advanced group was further divided into a steep K＜60 D group and steep K＞60 D group. Relevant patient details were documented, including gender, age, time of first consultation at our institute, treatment selections, best corrected visual acuity(BCVA), corneal curvature, topographic astigmatism (TA), and thinnest corneal thickness (TCT) before treatment. For all eyes with follow-up＞18mo after treatment, the corneal curvature,BCVA, TA, and TCT at the final follow-up point were recorded. The occurrence, timing, and treatment of related complications were also recorded.

RESULTS

The patients were 913 males and 249 females, with a gender ratio of 3.7:1. The average age at initial diagnosis was 20.9±6.0y(range, 6-58y). The average age was 20.5±5.5y (range, 6-48y)in males and 22.3±7.5y (range, 11-58y) in females (

＜0.001).Among the keratoconic eyes, 50.5% (941/1863) of the eyes wore RGP lenses, 6.9% (129/1863) underwent CXL, 11.7%(218/1863) had lamellar keratoplasty (LKP), and 30.9%(575/1863) had penetrating keratoplasty (PKP). In the eyes with steep K＜52 D, nonsurgical management (RGP) accounted for 83.4%, while in the eyes with steep K＞60 D, surgical management (CXL, LKP, and PKP) accounted for 90.6%(Figure 1).

There were 618 eyes for which the follow-up was more than 18mo after treatment. The 348 (56.3%) eyes wore RGP lenses,for which the follow-up was 54.0±31.9mo (range, 18.1-172.1mo).Totally 90 eyes (14.6%) underwent CXL, for which the follow-up was 22.3±3.7mo (range, 18.1-32.3mo). The 75 eyes (12.1%)had LKP, for which the follow-up was 47.9±30.5mo (range,18.2-156.1mo) and 105 eyes (17.0%) had PKP, for which the follow-up was 57.3±45.9mo (range, 18.3-241.9mo). The steeper curvature was accompanied by worse BCVA, greater TA, and thinner corneal thickness before treatment (Table 1).

Outcomes of Treatments

At the last time of follow-up, the best contact lens corrected visual acuity(BCLVA) after RGP lens wear was better than the best spectacle corrected visual acuity (BSCVA) before treatment(0.12±0.22 logMAR, 0.32±0.32 logMAR, respectively,

＜0.001,

=348). Higher steep K values were associated with lower BCLVA after treatment (

＜0.001). The mean steep K value improved from 50.9±5.9 to 51.4±6.9 D (

=0.009). The mean TA decreased from 3.5±2.4 to 3.1±2.3 D (

＜0.001).The mean TCT decreased from 480.1±46.1 to 466.2±48.4 μm(

＜0.001; Table 2).

The incidence of steep K progression in the eyes with RGP lenses was 14.4% (50/348). In the setting of larger initial steep K (＞52 D) 20.0% (27/135) had progression, while 10.8%(23/213) progressed in the setting of lower initial steep K(＜52 D;

=0.019). The 10.1% (35/348) of the eyes underwent keratoplasty after 29.6±20.1mo (range, 3.2-82.5mo) of RGP lens wear, with a significant difference between steep K＞52 D subgroup and steep K＜52 D subgroup (14.8% and 7.0%,respectively,

=0.027). In the 135 eyes in which steep K was＞52 D, the probability of future keratoplasty was significantly higher in the steep K＞60 D subgroup versus steep K＜60 D subgroup (32.0% and 10.9%, respectively,

=0.008; Table 3).

As of the last follow-up, BCVA improved from 0.21±0.19 logMAR to 0.10±0.11 logMAR after CXL (

＜0.001,

=90). Higher steep K values were associated with lower BCVA after treatment(

=0.003). The steep K, TA and TCT after treatment showed no significant difference compared to preoperative among all K subgroups (Table 2).

The incidence of steep K progression in the eyes that underwent CXL was 16.7% (15/90), with a significantly higher incidence in the steep K＞52 D subgroup compared to the steep K＜52 D subgroup (32.3% and 8.5%, respectively,

=0.007;Table 3).

At the last follow-up, the BCVA had improved from 0.94±0.57 to 0.24±0.21 logMAR after LKP (

＜0.001,

=75). The BCVA after LKP was 0.27±0.22 logMAR in the steep K＞60 D subgroup, and 0.15±0.12 logMAR in the subgroup in which steep K was between 52 to 60 D(

=0.025). The mean steep K value decreased from 62.7±5.3 to 46.6±2.7 D (

＜0.001). The mean TA decreased from 8.4±3.9 to 4.4±2.4 D (

＜0.001). The mean TCT increased from 380.5±62.5 to 545.6±42.5 μm (

＜0.001; Table 2).

At the last follow-up, the BCVA had improved from 1.22±0.53 to 0.27±0.32 logMAR after PKP (

＜0.001,

=105). The BCVA after PKP showed no significant difference among different curvature subgroups(

=0.611). The mean steep K value decreased from 67.3±6.7 to 47.8±4.1 D (

＜0.001). The mean TA decreased from 6.6±3.3 to 4.6±3.1 D (

＜0.001). The mean TCT increased from 356.8±75.3 to 504.2±37.4 μm (

＜0.001; Table 2).

The rate of immune rejection was 1.3% (1/75) after LKP and 8.6%(9/105) after PKP (

=0.047). After PKP rejection, the BCVA decreased to 0.53±0.42 logMAR (

=0.012).

Steep K is an important grading treatment indicator. When steep K is ＜52 D, RGP lenses should be recommended. It is the best time for LKP when the steep K ranges from 52 to 60 D.

When the steep K was ＜52 D, the BCVA after treatment in the eyes with RGP lens, CXL and LKP was 0.08±0.19, 0.07±0.08, and 0.15±0.11 logMAR respectively(

=0.017). Among them, the RGP group was better than LKP group (

=0.028); the difference did not reach significance between CXL group and LKP group (

=0.089), and the RGP and LKP group (

=0.052). The TA after treatment in the eyes with RGP lens, CXL and LKP was 2.3±1.6, 3.0±1.7, and 4.3±1.0 D, respectively (

＜0.001). Among them, the RGP group was lower than the LKP group (

=0.007) and CXL group (

=0.001); the CXL group and LKP group were not significantly different (

=0.08).

2.6 兩組不良反應(yīng)發(fā)生率比較 研究組不良反應(yīng)發(fā)生率低于對照組，差異有統(tǒng)計學(xué)意義(P<0.05)。見表6。

A total of 1162 patients (1863 eyes) with keratoconus who fit the following inclusion criteria were included: clinically evident keratoconus defined by the evidence of one or more of the following clinical findings using the slit-lamp microscopy in at least one eye: corneal stromal thinning, conical protrusion of the cornea at the apex, Fleischer ring, Vogt's striae, and anterior corneal scarring

.

Contralateral eyes of patients with clinical keratoconus in one eye were also included. Patients with keratoconus who did not receive any treatment were excluded.

When the steep K was ＞60 D, the BCVA and TA after treatment in the eyes with RGP lens, LKP and PKP showed no significant difference (Figure 2).

選種抗病品種，播種無菌種子；輪作倒茬病苗病秧清出田外深埋或燒毀，消滅病原載體。病秧不還田；推廣滴灌和配方施肥，推廣配方葉面肥，提高農(nóng)田作業(yè)質(zhì)量，規(guī)范田間管理，創(chuàng)造適合食葵生長發(fā)育的優(yōu)良環(huán)境條件，培育壯苗，抵抗病菌入侵；加強(qiáng)栽培管理合理施肥灌水，不偏施氮肥，生長后期打掉植株下部的黃葉、老葉，保持田間通分透光，增強(qiáng)植株的抗病能力。

The results of the univariate and multivariate regression analyses are summarized in Table 4. Univariate analyses revealed that treatment options to keratoconus was significantly associated with the steep K (

＜0.001), BCVA (

＜0.001), TA(

＜0.001), and TCT (

＜0.001). The following factors in the multivariate analysis remained a significant relation with the different treatments: steep K [odds ratio (OR)=1.208, 95%confidence interval (CI): 1.052-1.387], TA (OR=1.171, 95%CI:1.079-1.270), and TCT (OR=0.978, 95%CI: 0.971-0.984). A comparative analysis of steep K, TA, and TCT was performed to unveil a predictive index power. Unsurprisingly, the level of steep K, TA, and TCT followed the treatment choice between the keratoplasty and non-keratoplasty, although steep K reached the most significant meaning (AUC=0.947,

＜0.01)

TA (AUC=0.81,

=6.247,

＜0.01) and TCT (AUC=0.903,

=2.287,

=0.022; Table 5 and Figure 3). While looking for a promising steep K cut-off, we observed that 57.2 D allows for the diversification of whether the keratoplasty should be chosen, and showed a sensitivity of 87.8% with a specificity of 89.5%.

三是農(nóng)田灌溉工程規(guī)模化管理適應(yīng)了市場經(jīng)濟(jì)制度要求。政府投資或補(bǔ)助建設(shè)的農(nóng)田水利工程，一般是移交給工程所在村集體安排管理，而村集體安排的管理一般只是收取電力運(yùn)行費(fèi)，不收取工程折舊費(fèi)和維護(hù)費(fèi)，管理好的村莊在工程維修上由村集體給予補(bǔ)貼或按照 “一事一議”原則召開會議研究籌集，協(xié)調(diào)成本高昂，如果籌資協(xié)調(diào)不成還將導(dǎo)致工程癱瘓。以往村集體所管理的農(nóng)田水利工程大都只是一個福利工程，并且有可能只是村里一部分人的，這個福利工程是沒有維護(hù)經(jīng)費(fèi)保障的，隨時面臨著中止運(yùn)行的風(fēng)險。而規(guī)模化管理將農(nóng)田水利工程灌溉服務(wù)作為商品，進(jìn)行成本核算，工程運(yùn)行和維護(hù)等管理費(fèi)用有著落，有利于工程的可持續(xù)使用。……